Vitrolife AB (publ) (VTRLY) Stock Price, News & Analysis

Company Overview

Vitrolife AB (publ) is a Sweden‐based life science company specializing in products and systems for in vitro fertilization (IVF) and assisted reproductive technologies. Founded in 1994 and headquartered in Gothenburg, the company develops, manufactures and markets a comprehensive portfolio of consumables, culture media and instruments that support the entire IVF process, from gamete handling to embryo culture and cryopreservation.

The company’s product range includes embryo culture media, blastocyst media, vitrification solutions and pipetting tools designed to optimize laboratory workflows and improve outcomes for fertility clinics and patients. Vitrolife also offers advanced incubation systems with integrated time‐lapse imaging technology, enabling embryologists to monitor embryo development in real time and make more informed selection decisions.

Vitrolife serves a global customer base through its own sales organizations and a network of distributors across Europe, North America, Asia and other key markets. The company operates subsidiaries in several regions to provide localized technical support, training and regulatory expertise. Its geographic footprint and robust supply chain logistics are designed to ensure consistent product availability and adherence to international quality standards.

With a commitment to research and development, Vitrolife invests in innovation and collaborates with academic and clinical partners to advance reproductive medicine. The company’s management team comprises professionals with deep expertise in biotechnology and medical device commercialization, guiding Vitrolife’s strategy to expand its presence in the rapidly evolving field of fertility treatment.

Key Stats

• Today's Range: $15.00 to $15.00
• 50-Day Range: $14.98 to $15.00
• 52-Week Range: $14.62 to $17.66
• Volume: N/A
• Average Volume: 213 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VTRLY Stock Analysis - Frequently Asked Questions

How have VTRLY shares performed this year?

Vitrolife AB (publ)'s stock was trading at $18.7470 at the start of the year. Since then, VTRLY stock has decreased by 20.0% and is now trading at $15.00.

How do I buy shares of Vitrolife AB (publ)?

Shares of VTRLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 10/08/2025
• Next Earnings (Estimated): 10/23/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:VTRLY
• CIK: N/A
• Web: www.vitrolife.com
• Phone: 46-3-17-21-80-00
• Fax: N/A
• Employees: 1,132
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A